Old Web
English
Sign In
Acemap
>
authorDetail
>
Isabella Visuri
Isabella Visuri
Medicine
Internal medicine
Oncology
Tumor necrosis factor alpha
Adalimumab
5
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Predictors of drug survival: A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register.
2021
Alimentary Pharmacology & Therapeutics
Isabella Visuri
Carl Eriksson
Ola Olén
Yang Cao
Emelie Mårdberg
Olof Grip
Anders Gustavsson
Henrik Hjortswang
Pontus Karling
Scott Montgomery
Pär Myrelid
Jonas F. Ludvigsson
Jonas Halfvarson
Malin Olsson
Andree Lauber
Anders Magnuson
Show All
Source
Cite
Save
Citations (2)
Golimumab är effektivt vid ulcerös kolit under svenska förhållanden. Interimsanalys av en svensk prospektiv multi-centerstudie, GO-SWIBREG
2018
Carl Eriksson
D. Bergenmalm
Lina Vigren
Linda Nilsson
Isabella Visuri
H. Hjortswang
Ruzan Udumyan
Sven Almer
M Seddighzadeh
Erik Hertervig
Per Karlén
H. Stridh
Jonas Halfvarson
Show All
Source
Cite
Save
Citations (0)
Does Previous Exposure to Anti--‐TNF Influence Treatment Outcomes in IBD Patients on Anti--‐TNF Therapy? : A project in collaboration with the Swedish IBD Registry “SWIBREG”
2016
Isabella Visuri
Show All
Source
Cite
Save
Citations (0)
1